Is it safe to take buspirone 5 mg daily together with diltiazem (Cardizem) 180 mg daily?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Buspirone 5 mg with Cardizem (Diltiazem) 180 mg Daily: Safety Assessment

Yes, this combination can be used together, but the buspirone dose of 5 mg is likely too high and should be reduced to 2.5 mg once or twice daily to avoid excessive side effects and toxicity.

The Critical Drug Interaction

Diltiazem is a moderate-to-strong inhibitor of CYP3A4, the primary enzyme responsible for buspirone's first-pass metabolism. This interaction creates a clinically significant pharmacokinetic effect:

  • Diltiazem increases buspirone AUC by 5.5-fold (450% increase)
  • Buspirone peak concentrations (Cmax) increase by 4.1-fold (310% increase)
  • The elimination half-life remains unchanged, but total drug exposure is dramatically elevated 1, 2, 3

Recommended Dosing Strategy

When combining these medications:

  1. Start buspirone at 2.5 mg once daily (not the standard 5 mg dose)
  2. If needed for efficacy, may increase to 2.5 mg twice daily
  3. Monitor closely for buspirone-related adverse effects
  4. Base all subsequent dose adjustments on clinical assessment 1, 2

The FDA labeling explicitly states: "If the two drugs are to be used in combination, a low dose of buspirone (e.g., 2.5 mg b.i.d.) is recommended" 1.

Clinical Manifestations to Monitor

Enhanced buspirone effects and toxicity may include:

  • Dizziness and lightheadedness
  • Drowsiness and somnolence
  • Headache
  • Nausea
  • Asthenia (weakness)

These adverse events occurred more frequently when diltiazem was combined with buspirone in clinical studies 1, 3.

Mechanism and Context

Both drugs are substrates of CYP3A4, but diltiazem acts as an inhibitor of this enzyme system. When diltiazem blocks CYP3A4, buspirone's extensive first-pass metabolism is significantly impaired, leading to much higher systemic concentrations than would occur with buspirone alone 3.

Research demonstrates that diltiazem's effect on buspirone is actually stronger than verapamil's effect (5.5-fold vs 3.4-fold AUC increase), making this a particularly potent interaction 3.

Important Caveats

  • Consistency with food: Buspirone should be taken consistently either always with food or always without food, as this affects absorption 1
  • Avoid grapefruit juice: This would further inhibit CYP3A4 and compound the interaction 1
  • The 180 mg diltiazem dose is substantial and represents a moderate-to-high dose, making the CYP3A4 inhibition clinically relevant

Bottom Line

The combination is not contraindicated but requires proactive dose reduction of buspirone to approximately 50% of the usual starting dose (2.5 mg instead of 5 mg). Your current buspirone dose of 5 mg daily with diltiazem 180 mg is delivering buspirone exposure equivalent to approximately 25-30 mg without the interaction, which increases the risk of adverse effects without additional therapeutic benefit.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.